MedTrace Logo

Pediatric Primary Immunodeficiency Disease (PID) in China

NCT03252548 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2018-01-03

No results posted yet for this study

Summary

This study is a prospective cohort study of children diagnosed with primary immunodeficiency disease (PID). The aim is to investigate the clinical characteristics and prognosis of PID in Chinese children.

Conditions

  • Primary Immunodeficiency Disease

Sponsors & Collaborators

  • Capital Institute of Pediatrics, China

    collaborator OTHER

  • Shenzhen Children's Hospital

    collaborator OTHER_GOV

  • Beijing Children's Hospital

    lead OTHER

Principal Investigators

  • kunling shen, MD,PhD · Beijing Children's Hospital, Capital Medical University, China

  • jianxin he, MD,PhD · Beijing Children's Hospital, Capital Medical University, China

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-31
Primary Completion
2022-08-31
Completion
2022-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03252548 on ClinicalTrials.gov